Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Cost of Revenue (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Cost of Revenue for 17 consecutive years, with $4.1 billion as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 14.86% to $4.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 billion through Dec 2025, changed 0.22% year-over-year, with the annual reading at $13.9 billion for FY2025, 0.23% changed from the prior year.
  • Cost of Revenue for Q4 2025 was $4.1 billion at Bristol Myers Squibb, up from $3.4 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $4.8 billion in Q4 2024, with the low at $2.3 billion in Q3 2021.
  • Average Cost of Revenue over 5 years is $2.9 billion, with a median of $2.8 billion recorded in 2021.
  • The sharpest move saw Cost of Revenue fell 22.42% in 2021, then skyrocketed 75.3% in 2024.
  • Over 5 years, Cost of Revenue stood at $2.4 billion in 2021, then rose by 10.06% to $2.6 billion in 2022, then rose by 5.86% to $2.7 billion in 2023, then surged by 75.3% to $4.8 billion in 2024, then fell by 14.86% to $4.1 billion in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $4.1 billion, $3.4 billion, and $3.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.